Efgartigimod and Ravulizumab for Treating Acetylcholine Receptor Auto-antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis: Indirect Treatment Comparison.
Adv Ther
; 41(6): 2486-2499, 2024 Jun.
Article
in En
| MEDLINE
| ID: mdl-38642198
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, Cholinergic
/
Antibodies, Monoclonal, Humanized
/
Myasthenia Gravis
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Adv Ther
Journal subject:
TERAPEUTICA
Year:
2024
Document type:
Article
Affiliation country:
Country of publication: